FDA Adverse Event Malfunction Summary report: N

CA090, DIRECT DRIVE LCA 3/BX

MDR report key: 6358936 · Received February 24, 2017

Report

Report Number
2027111-2017-00745
Event Type
Malfunction
Date Received
February 24, 2017
Date of Event
March 7, 2016
Report Date
February 24, 2017
Manufacturer
APPLIED MEDICAL RESOURCES
Product Code
FZP
UDI-DI
00607915117306
PMA / PMN Number
22
Removal / Correction Number
Z-1621-2016
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE ENGINEERING EVALUATION WAS ASSIGNED AND COMPLETED PRIOR TO JUNE 1, 2016, THEREFORE AN INVESTIGATION SUMMARY IS NOT REQUIRED. ON MARCH 18, 2016, APPLIED MEDICAL ISSUED A VOLUNTARY CLASS II RECALL OF THE CA090 DIRECT DRIVE CLIP APPLIER DUE TO INCREASED CUSTOMER FEEDBACK INDICATING INCONSISTENT CLIP APPLICATION, WHICH HAS THE POTENTIAL TO LEAD TO UNOCCLUDED VESSELS. AN INTERNAL CORRECTIVE AND PREVENTATIVE ACTION (CAPA) HAS BEEN INITIATED TO CONDUCT A THOROUGH INVESTIGATION AND IMPLEMENT APPROPRIATE CORRECTIVE ACTIONS. FDA HAS ISSUED RECALL NUMBER Z-1621-2016 FOR THIS RECALL. THIS REPORT IS BEING FILED AS A RESULT OF A RE-REVIEW OF APPLIED MEDICAL COMPLAINTS RECEIVED BETWEEN JUNE 1, 2014 AND MAY 31, 2016. THIS RETROSPECTIVE REVIEW WAS ASSOCIATED WITH A QUALITY MANAGEMENT SYSTEM (QMS) COMPLIANCE ACTION PLAN DEVELOPED AND PRESENTED TO FDA TO ADDRESS AN APRIL 10, 2015 WARNING LETTER. APPLIED MEDICAL HAS REVISED ITS MDR REPORTING CRITERIA TO BE MORE CONSERVATIVE AND HAS IMPROVED COMPLAINT HANDLING AND MDR REPORTING PROCESSES. THE REVIEWS ENSURED THAT RECENT REPORTABLE EVENTS WERE APPROPRIATELY IDENTIFIED AND REPORTED TO THE DESIGNATED REGULATORY AUTHORITY(IES). THIS REPORT, WHICH REPRESENTS THE INITIAL AND FINAL REPORTS COMBINED, IS BEING SUBMITTED BASED ON THE FINDINGS OF THAT RETROSPECTIVE REVIEW. IN ACCORDANCE WITH 21 CFR 803.56, IF ADDITIONAL INFORMATION IS OBTAINED WHICH WAS NOT KNOWN OR WAS NOT AVAILABLE WHEN THIS REPORT WAS SUBMITTED, THEN A SUPPLEMENTAL REPORT WILL BE SUBMITTED TO THE FDA.

Description of Event or Problem · 1

"SURGEON REQUIRED THREE OF PRODUCTS TO BE OPENED. REF CA090 LOT - 1202652 WAS INCLUDED IN KIT WOULD ONLY DISPENSE ONE CLIP REQUIRING SECOND DEVICE TO BE OPENED. REF CA090 LOT - 1214521 PRODUCT TIMES TWO OPENED. CLIPS WERE DISPENSING WITHOUT BEING FIRED. THEY WERE JUST FALLING OUT INTO PATIENT. SURGEON WAS ABLE TO GET ENOUGH CLIPS OUT OF PRODUCT TO COMPLETE CASE BUT WE OPENED THREE DEVICES. I FELT THAT WE SHOULD GET CREDIT FOR TWO." PATIENT STATUS - PATIENT WAS DISCHARGE HOME SAME DAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
138676 CA090, DIRECT DRIVE LCA 3/BX FZP FZP APPLIED MEDICAL RESOURCES 22 1214521 00607915117306

Patients

Seq Age Sex Outcome Treatment
1 2 ADDITIONAL CA090